Rho(D) immune globulin shortage and fetal Rh(D) screening with cell-free DNA [0.03%]
Rh(D)免疫球蛋白短缺与采用细胞游离DNA进行胎儿Rh(D)筛查
Matthew R Grace,Brighton Goodhue,Neeta L Vora
Matthew R Grace
Purpose of review: Despite the availability of Rh(D) immune globulin (RhIg) to prevent alloimmunization in Rh(D)-negative pregnant patients, anti-Rh(D) alloimmunization remains a prevalent cause of hemolytic disease of th...
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025 [0.03%]
2025年子宫内膜癌患者的内分泌治疗现状及未来展望
Fernanda B Musa,Kathleen N Moore,Vivek Podder et al.
Fernanda B Musa et al.
Purpose of review: Endometrial cancer (EC) is rising in incidence, particularly in younger, premenopausal women, due to increasing rates of obesity and delayed childbearing. This review evaluates current and emerging endo...
Contemporary uses of "lethal" or "life limiting" terminology in perinatal research [0.03%]
围产期研究中使用“致命的”或“生命限制性”的术语的现状
Luke A Gatta,Allison M McCarthy,Sarah S Osmundson
Luke A Gatta
Purpose of review: A life-limiting fetal diagnosis (LLD) refers to a medical condition identified during pregnancy that is expected to lead to stillbirth, preclude ex utero survival, or significantly reduce neonatal life ...
Prevention of gynecological cancers: cervical cancer screening in Turkey: a role model for the world [0.03%]
土耳其的宫颈癌筛查：预防妇科癌症的典范之举
Utku Akgör,Bilal Esat Temiz,Murat Gültekin
Utku Akgör
Purpose of review: This review examines Turkey's cervical cancer screening programme, highlighting its evolution from a cytology-based approach to a more effective HPV-based strategy. The review is timely given the global...
Prevention of gynecological cancers: cervical cancer screening in Turkey: a role model for the world [0.03%]
土耳其的宫颈癌筛查：供全球借鉴的模式——防治妇科癌症系列评论之三
Utku Akgör,Bilal Esat Temiz,Murat Gultekin
Utku Akgör
Purpose of review: This review examines Turkey's cervical cancer screening programme, highlighting its evolution from a cytology-based approach to a more effective HPV-based strategy. The review is timely given the global...
Teresa Khoo,Daniel Karlin,Christopher Pietras
Teresa Khoo
Purpose of review: This review assesses the impact of early integration of palliative care and the disparities that exist among patients with gynecologic malignancies. It also highlights the recent advances in symptom man...
Current opinions: updates on the changing landscape in the management of cervical cancer [0.03%]
当前观点：宫颈癌治疗格局变化的更新意见
Puja S Venkat,Alexandra H Smick,Ritu Salani
Puja S Venkat
Purpose of review: To review the recent updates in the management of cervical cancer across all stages of the disease. Recent findings: ...
The advent of immune checkpoint inhibition for the treatment of patients with primary advanced or recurrent dMMR/MSI high endometrial cancer in 2025 [0.03%]
2025年错配修复缺陷型或高度微卫星不稳定性晚期或复发性子宫内膜癌患者免疫检查点抑制治疗的应用展望
Tarik Silk,Kari E Hacker,Whitfield Growdon et al.
Tarik Silk et al.
Purpose of review: The Cancer Genome Atlas identified four distinct molecular subtypes of endometrial cancer (EC): POLE mutated, mismatch repair deficient (dMMR), copy number low, and copy number high. The goal of this re...